Peptide Law by State

Federal reclassification sets the floor; state pharmacy boards set the ceiling. The post-April-15 access landscape varies meaningfully by state. Coverage rolls out by state — full grid by July PCAC.

Permissive states

Standard compounding pharmacy access; minimal additional friction.

• Texas — Texas runs one of the most workable compounding pharmacy regimes in the country and is a primary hub for national compounding operations.

Restrictive-tier states

Stricter non-resident pharmacy regimes, telehealth limits, or layered oversight.

• California — California maintains one of the strictest non-resident pharmacy licensing regimes in the country, materially limiting which compounders can ship in.
• New York — New York maintains a restrictive non-resident pharmacy regime and additional state-level oversight on certain compounded categories.

How the tier classification works

• Permissive (24 states): Standard non-resident pharmacy registration; broad telehealth latitude; no peptide-specific layered oversight. AL, AZ, AR, FL, GA, ID, IN, KS, KY, LA, MS, MO, MT, NE, NV, ND, OK, SC, SD, TN, TX, UT, WV, WY.
• Moderate (17 states): 1-2 additional verification steps. AK, CO, DE, IA, ME, MI, MN, NH, NM, NC, OH, OR, PA, RI, VA, WA, WI.
• Restrictive (10 states + DC): Stricter regimes. CA, CT, HI, IL, MD, MA, NJ, NY, VT, DC.